PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
test
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Diversification

Asset Allocation


GBDC 7.14%REGN 7.14%COR 7.14%AXP 7.14%BIIB 7.14%PM 7.14%AMGN 7.14%CHKP 7.14%VYM 7.14%XLU 7.14%FXAIX 7.14%PG 7.14%NSRGY 7.14%PGF 7.14%EquityEquityPreferred StockPreferred Stock
PositionCategory/SectorTarget Weight
AMGN
Amgen Inc.
Healthcare
7.14%
AXP
American Express Company
Financial Services
7.14%
BIIB
Biogen Inc.
Healthcare
7.14%
CHKP
Check Point Software Technologies Ltd.
Technology
7.14%
COR
Cencora Inc.
Healthcare
7.14%
FXAIX
Fidelity 500 Index Fund
Large Cap Blend Equities
7.14%
GBDC
Golub Capital BDC, Inc.
Financial Services
7.14%
NSRGY
Nestlé S.A.
Consumer Defensive
7.14%
PG
The Procter & Gamble Company
Consumer Defensive
7.14%
PGF
Invesco Financial Preferred ETF
Preferred Stock/Convertible Bonds
7.14%
PM
Philip Morris International Inc.
Consumer Defensive
7.14%
REGN
Regeneron Pharmaceuticals, Inc.
Healthcare
7.14%
VYM
Vanguard High Dividend Yield ETF
Dividend, Large Cap Value Equities
7.14%
XLU
Utilities Select Sector SPDR Fund
Utilities Equities
7.14%

Performance

Performance Chart

The chart shows the growth of an initial investment of $10,000 in test, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends. The portfolio is rebalanced every 3 months.


-15.00%-10.00%-5.00%0.00%5.00%10.00%SeptemberOctoberNovemberDecember2025February
-8.34%
6.51%
test
Benchmark (^GSPC)
Portfolio components

The earliest data available for this chart is May 10, 2011, corresponding to the inception date of FXAIX

Returns By Period

As of Feb 27, 2025, the test returned 7.63% Year-To-Date and 9.53% of annualized return in the last 10 years.


YTD1M6M1Y5Y*10Y*
^GSPC
S&P 500
1.27%-0.94%6.51%17.29%15.12%10.99%
test6.65%2.82%-8.20%4.93%12.08%7.89%
GBDC
Golub Capital BDC, Inc.
2.64%-1.21%8.94%9.68%9.65%8.04%
REGN
Regeneron Pharmaceuticals, Inc.
-0.63%3.14%-39.96%-28.33%9.79%5.41%
COR
Cencora Inc.
11.81%-1.52%5.97%7.10%26.04%10.94%
AXP
American Express Company
0.00%-6.60%14.52%37.31%23.68%15.42%
BIIB
Biogen Inc.
-8.13%-3.44%-31.41%-36.64%-14.60%-10.31%
PM
Philip Morris International Inc.
28.57%19.99%29.10%79.71%19.99%12.05%
AMGN
Amgen Inc.
18.50%10.19%-5.95%13.79%12.39%9.88%
PGF
Invesco Financial Preferred ETF
2.80%0.27%-0.42%4.12%1.36%3.35%
CHKP
Check Point Software Technologies Ltd.
18.33%8.86%15.30%36.29%16.38%10.14%
VYM
Vanguard High Dividend Yield ETF
4.17%0.81%6.88%18.69%13.57%10.01%
XLU
Utilities Select Sector SPDR Fund
5.43%4.20%6.98%32.63%8.56%9.60%
FXAIX
Fidelity 500 Index Fund
1.45%-1.73%7.21%19.06%16.92%12.75%
PG
The Procter & Gamble Company
2.80%3.07%1.96%9.67%11.40%10.28%
NSRGY
Nestlé S.A.
19.52%13.14%-9.11%-3.80%1.64%5.19%
*Annualized

Monthly Returns

The table below presents the monthly returns of test, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
20253.94%6.65%
20245.06%0.18%2.42%-2.91%5.12%1.98%3.85%4.68%-3.46%-6.34%-0.04%-5.28%4.42%
20233.53%-3.39%3.82%1.01%-5.07%3.02%1.95%2.11%-1.41%-2.76%6.68%4.69%14.34%
2022-0.88%1.19%4.12%-3.64%0.93%-7.61%2.98%-1.83%-0.69%9.52%5.42%-4.10%4.32%
20211.19%-3.17%6.57%2.53%1.37%4.63%2.20%3.74%-5.98%3.22%-3.64%6.17%19.54%
2020-2.93%0.09%-3.07%6.04%6.03%-0.02%4.06%2.08%-3.28%-4.74%3.21%0.97%7.98%
20198.40%2.54%-2.45%-3.35%-5.28%5.73%1.13%-0.56%-0.11%4.98%5.24%1.64%18.39%
20181.81%-6.26%-1.25%-2.67%0.41%3.82%5.50%4.31%0.72%-6.22%4.76%-6.98%-3.13%
20172.71%5.06%0.22%-0.23%5.34%3.56%1.01%0.71%-1.71%-2.90%-1.00%1.18%14.48%
2016-10.77%-2.94%2.15%2.03%1.56%-3.63%9.14%-1.38%-0.15%-7.11%2.94%0.65%-8.62%
20150.76%2.37%2.43%-0.48%3.88%-1.91%1.87%-5.93%-4.25%9.13%-0.43%0.72%7.58%
20140.68%6.79%-3.39%-1.43%3.95%-0.93%2.32%5.75%-0.90%6.05%2.67%0.33%23.49%

Expense Ratio

test has an expense ratio of 0.06%, which is considered low compared to other funds. Below you can find the expense ratios of portfolio funds side-by-side and effortlessly compare their relative costs.


Expense ratio chart for PGF: current value at 0.62% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.62%
Expense ratio chart for XLU: current value at 0.13% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.13%
Expense ratio chart for VYM: current value at 0.06% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.06%
Expense ratio chart for FXAIX: current value at 0.02% compared with the broader market ranging from 0.00% to 2.12%.0.50%1.00%1.50%2.00%0.02%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of test is 35, indicating average performance compared to other portfolios on our website. Here’s a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of test is 3535
Overall Rank
The Sharpe Ratio Rank of test is 4242
Sharpe Ratio Rank
The Sortino Ratio Rank of test is 4141
Sortino Ratio Rank
The Omega Ratio Rank of test is 4242
Omega Ratio Rank
The Calmar Ratio Rank of test is 2828
Calmar Ratio Rank
The Martin Ratio Rank of test is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

This table presents a comparison of risk-adjusted performance metrics for positions. Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for test, currently valued at 0.40, compared to the broader market-6.00-4.00-2.000.002.004.000.401.34
The chart of Sortino ratio for test, currently valued at 0.61, compared to the broader market-6.00-4.00-2.000.002.004.000.611.83
The chart of Omega ratio for test, currently valued at 1.08, compared to the broader market0.400.600.801.001.201.401.601.801.081.25
The chart of Calmar ratio for test, currently valued at 0.30, compared to the broader market0.002.004.006.008.0010.000.302.01
The chart of Martin ratio for test, currently valued at 0.68, compared to the broader market0.0010.0020.0030.000.688.09
test
^GSPC

Portfolio components
Sharpe ratioSortino ratioOmega ratioCalmar ratioMartin ratio
GBDC
Golub Capital BDC, Inc.
0.681.041.130.591.30
REGN
Regeneron Pharmaceuticals, Inc.
-1.15-1.530.81-0.62-1.21
COR
Cencora Inc.
0.370.661.080.561.10
AXP
American Express Company
1.652.291.303.6911.77
BIIB
Biogen Inc.
-1.46-2.150.76-0.52-1.64
PM
Philip Morris International Inc.
3.354.991.697.0622.32
AMGN
Amgen Inc.
0.350.701.090.400.96
PGF
Invesco Financial Preferred ETF
0.370.581.070.281.12
CHKP
Check Point Software Technologies Ltd.
1.461.861.322.045.24
VYM
Vanguard High Dividend Yield ETF
1.682.401.303.068.79
XLU
Utilities Select Sector SPDR Fund
2.142.901.371.789.50
FXAIX
Fidelity 500 Index Fund
1.461.991.272.219.02
PG
The Procter & Gamble Company
0.560.831.120.772.21
NSRGY
Nestlé S.A.
-0.31-0.330.96-0.17-0.48

The current test Sharpe ratio is 1.28. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Compared to the broad market, where average Sharpe ratios range from 1.02 to 1.64, this portfolio's current Sharpe ratio lies between the 25th and 75th percentiles. This indicates that the its risk-adjusted performance is in line with the majority of portfolios. This suggests a balanced approach to risk and return, which might be suitable for a broad range of investors.

Use the chart below to compare the Sharpe ratio of test with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio0.000.501.001.502.002.503.003.50SeptemberOctoberNovemberDecember2025February
0.40
1.34
test
Benchmark (^GSPC)
Portfolio components

Dividends

Dividend yield

test provided a 2.74% dividend yield over the last twelve months.


TTM20242023202220212020201920182017201620152014
Portfolio2.74%2.97%2.86%2.74%2.43%2.67%2.55%3.02%2.57%2.82%2.75%2.59%
GBDC
Golub Capital BDC, Inc.
11.38%12.14%10.00%9.35%7.58%8.37%6.99%8.49%7.47%8.32%7.70%7.14%
REGN
Regeneron Pharmaceuticals, Inc.
0.12%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
COR
Cencora Inc.
0.85%0.93%0.96%1.13%1.34%1.74%1.88%2.07%1.61%1.77%1.17%1.10%
AXP
American Express Company
0.95%0.91%1.24%1.35%1.05%1.42%1.29%1.51%1.32%1.61%1.58%1.05%
BIIB
Biogen Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
PM
Philip Morris International Inc.
3.43%4.40%5.46%4.98%5.16%5.73%5.43%6.73%3.99%4.50%4.60%4.76%
AMGN
Amgen Inc.
2.98%3.45%2.96%2.95%3.13%2.78%2.41%2.71%2.65%2.74%1.95%1.53%
PGF
Invesco Financial Preferred ETF
6.19%6.24%6.15%5.95%4.68%4.91%5.14%5.73%5.32%5.92%5.60%5.92%
CHKP
Check Point Software Technologies Ltd.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VYM
Vanguard High Dividend Yield ETF
2.63%2.74%3.12%3.01%2.76%3.18%3.03%3.40%2.80%2.91%3.22%2.78%
XLU
Utilities Select Sector SPDR Fund
2.81%2.96%3.39%2.92%2.79%3.14%2.95%3.33%3.33%3.42%3.67%3.19%
FXAIX
Fidelity 500 Index Fund
1.23%1.25%1.45%1.69%1.22%1.60%1.95%2.07%1.81%2.01%2.56%2.63%
PG
The Procter & Gamble Company
2.35%2.36%2.55%2.38%2.08%2.24%2.37%3.09%2.98%3.18%3.32%2.78%
NSRGY
Nestlé S.A.
3.49%4.17%2.76%2.64%2.18%2.34%2.24%3.12%2.68%3.16%3.11%3.32%

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-15.00%-10.00%-5.00%0.00%SeptemberOctoberNovemberDecember2025February
-8.69%
-3.06%
test
Benchmark (^GSPC)
Portfolio components

Worst Drawdowns

The table below displays the maximum drawdowns of the test. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the test was 21.23%, occurring on Mar 23, 2020. Recovery took 47 trading sessions.

The current test drawdown is 0.76%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-21.23%Mar 5, 202013Mar 23, 202047May 29, 202060
-20.4%Jul 21, 2015143Feb 11, 2016328Jun 1, 2017471
-16.66%Apr 21, 202240Jun 16, 2022115Nov 30, 2022155
-15.19%Sep 3, 202490Jan 10, 2025
-15.13%Jul 25, 2017196May 3, 2018102Sep 27, 2018298

Volatility

Volatility Chart

The current test volatility is 3.12%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


2.00%3.00%4.00%5.00%6.00%SeptemberOctoberNovemberDecember2025February
3.12%
3.10%
test
Benchmark (^GSPC)
Portfolio components

Diversification

Asset Correlations Table

The table below displays the correlation coefficients between the individual components of the portfolio, the entire portfolio, and the chosen benchmark.

GBDCPGFNSRGYREGNCHKPCORXLUPMBIIBPGAXPAMGNFXAIXVYM
GBDC1.000.220.190.160.210.190.230.210.210.170.320.210.390.39
PGF0.221.000.270.210.230.190.300.250.240.220.320.240.420.40
NSRGY0.190.271.000.200.240.240.330.330.240.360.250.280.380.38
REGN0.160.210.201.000.280.310.170.200.480.230.260.510.410.35
CHKP0.210.230.240.281.000.280.220.240.300.260.340.300.500.43
COR0.190.190.240.310.281.000.270.300.340.310.330.420.430.47
XLU0.230.300.330.170.220.271.000.430.220.510.290.320.430.53
PM0.210.250.330.200.240.300.431.000.260.460.330.330.440.54
BIIB0.210.240.240.480.300.340.220.261.000.270.350.540.480.46
PG0.170.220.360.230.260.310.510.460.271.000.300.370.450.53
AXP0.320.320.250.260.340.330.290.330.350.301.000.350.690.70
AMGN0.210.240.280.510.300.420.320.330.540.370.351.000.500.53
FXAIX0.390.420.380.410.500.430.430.440.480.450.690.501.000.88
VYM0.390.400.380.350.430.470.530.540.460.530.700.530.881.00
The correlation results are calculated based on daily price changes starting from May 11, 2011
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab